Curative Biosciences Inc
OTC:CBDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Curative Biosciences Inc
Total Current Liabilities
Curative Biosciences Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Curative Biosciences Inc
OTC:CBDX
|
Total Current Liabilities
$719.5k
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Liabilities
$54.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Liabilities
$23.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
11%
|
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Liabilities
$37B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Liabilities
$28.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Liabilities
$35.2B
|
CAGR 3-Years
27%
|
CAGR 5-Years
23%
|
CAGR 10-Years
16%
|
|
Curative Biosciences Inc
Glance View
Curative Biosciences, Inc. is engaged in the development and marketing of novel therapeutics. The company is headquartered in Miami, Florida. The company went IPO on 2004-08-26. The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The firm through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
See Also
What is Curative Biosciences Inc's Total Current Liabilities?
Total Current Liabilities
719.5k
USD
Based on the financial report for Mar 31, 2018, Curative Biosciences Inc's Total Current Liabilities amounts to 719.5k USD.
What is Curative Biosciences Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
4%
Over the last year, the Total Current Liabilities growth was 17%. The average annual Total Current Liabilities growth rates for Curative Biosciences Inc have been 8% over the past three years , 4% over the past five years .
